Intestine and Lower Gastrointestinal Tract · 23 October 2024

Short-Course TNT Outperforms Long-Course Treatment in Rectal Cancer

A multi-institutional review of 857 patients demonstrated that short-course total neoadjuvant therapy (sc TNT) significantly increases complete response (CR) rates in rectal cancer compared to long-course chemoradiation (lCRT). Specifically, CR rates were 34.1% for sc TNT versus 20.3% for lCRT. Notably, patients completing 5-6 months of consolidation chemotherapy had a CR rate of 42.9%. Despite this, three-year progression-free survival rates were analogous between the two treatments.

Journal Article by Bauer PS, Gamboa AC (…) Wise PE et 12 al. in J Surg Oncol

read the whole article in J Surg Oncol

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in Intestine and Lower Gastrointestinal Tract.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

More in Intestine and Lower Gastrointestinal Tract

The latest stitches

Lancet4 Nov 2026

Colorectal cancer: shorter chemo, fewer side effects

A Japanese randomized trial found that a 14-day schedule of trifluridine-tipiracil plus bevacizumab keeps patients with metastatic colorectal cancer alive as long as the standard 28-day schedule, with far less toxicity.

Br J Surg4 Nov 2026

Robot matches laparoscopy for rectal cancer survival

Five years after surgery for low rectal cancer, patients operated on robotically did as well as those operated on laparoscopically, according to a randomized trial from three Korean centres.

Ann Surg Oncol2 Nov 2026

Smoking linked to weaker rectal cancer response

Patients smoking at diagnosis were less likely to have a favorable response to treatment before rectal cancer surgery; former smokers were not.

All papers in Intestine and Lower Gastrointestinal Tract →